Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!
$4.78
+0.0800 (+1.70%)
At Close: May 09, 2024
Forecast Earnings Fundamentals Insider Trading Signals Historical Prices Predictions News Profile

Range Low Price High Price Comment
30 days $4.28 $5.69 Thursday, 9th May 2024 MBRX stock ended at $4.78. This is 1.70% more than the trading day before Wednesday, 8th May 2024. During the day the stock fluctuated 9.54% from a day low at $4.61 to a day high of $5.05.
90 days $0.400 $6.23
52 weeks $0.338 $6.23

Historical Moleculin Biotech Inc prices

Date Open High Low Close Volume
Jun 16, 2023 $0.587 $0.590 $0.561 $0.570 116 288
Jun 15, 2023 $0.547 $0.606 $0.547 $0.590 821 771
Jun 14, 2023 $0.625 $0.630 $0.590 $0.595 102 824
Jun 13, 2023 $0.643 $0.643 $0.625 $0.625 43 556
Jun 12, 2023 $0.600 $0.638 $0.600 $0.630 62 673
Jun 09, 2023 $0.630 $0.643 $0.600 $0.600 74 350
Jun 08, 2023 $0.655 $0.655 $0.619 $0.619 67 713
Jun 07, 2023 $0.611 $0.655 $0.610 $0.655 44 353
Jun 06, 2023 $0.580 $0.637 $0.575 $0.630 35 283
Jun 05, 2023 $0.590 $0.630 $0.570 $0.589 98 265
Jun 02, 2023 $0.575 $0.611 $0.575 $0.609 71 294
Jun 01, 2023 $0.634 $0.638 $0.570 $0.572 118 644
May 31, 2023 $0.611 $0.648 $0.600 $0.634 73 510
May 30, 2023 $0.579 $0.643 $0.563 $0.624 118 903
May 26, 2023 $0.570 $0.630 $0.561 $0.579 261 921
May 25, 2023 $0.640 $0.658 $0.624 $0.624 66 880
May 24, 2023 $0.650 $0.669 $0.625 $0.655 151 205
May 23, 2023 $0.620 $0.650 $0.610 $0.640 124 287
May 22, 2023 $0.630 $0.676 $0.605 $0.620 333 613
May 19, 2023 $0.630 $0.630 $0.605 $0.628 89 186
May 18, 2023 $0.635 $0.637 $0.607 $0.637 101 869
May 17, 2023 $0.600 $0.641 $0.600 $0.638 235 522
May 16, 2023 $0.625 $0.660 $0.590 $0.611 263 276
May 15, 2023 $0.647 $0.668 $0.605 $0.616 399 034
May 12, 2023 $0.751 $0.780 $0.581 $0.667 372 787
Click to get the best stock tips daily for free!

About Moleculin Biotech Inc

Moleculin Biotech Moleculin Biotech, Inc., a clinical-stage pharmaceutical company, focuses on the development of drug candidates for the treatment of highly resistant tumors and viruses. Its lead drug candidate is Annamycin that is in Phase 1/2 studies for the treatment of relapsed or refractory acute myeloid leukemia (AML) and cancers metastasized to the lungs. The company's flagship immune/transcription modulator is WP1066, which is in Phase I clinical trial fo... MBRX Profile

Golden Star

Ticker Date Change Price
PAG May 07 1.87% $153.22
WMT May 06 0.95% $59.87
UNP May 06 3.09% $239.21
JPM May 06 2.86% $192.00
ASH May 03 2.10% $95.85
INVH May 03 1.72% $34.39
INGR May 03 4.72% $114.56
VCSH May 03 0.0260% $76.93
BNDX May 03 0.205% $48.68
BBCA May 03 1.93% $65.44
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT